Search results
Pharma Stock Roundup: LLY to Buy Morphic, PFE Advances Obesity Drug Development
Zacks via Yahoo News· 3 days agoEli Lilly (LLY) offers to acquire Morphic Therapeutics for $3.2 billion. Pfizer (PFE) selects a...
Kymera's (KYMR) Partner SNY to Expand Ongoing HS and AD Studies
Zacks via Yahoo News· 6 days agoComplete responses in two patients with cHL were observed. KT-333 was well-tolerated with phase I ...
Scientists unveil prototype spacesuit system that recycles urine as drinking water
CNN via Yahoo News· 3 days agoResearchers at Cornell University have designed a novel in-suit urine collection and filtration...
Pre-existing sleep disturbances linked to higher COVID mortality rates — and more health headlines...
Yahoo Canada Style· 2 days agoThis article is for informational purposes only and is not a substitute for professional medical...
Strength Seen in IDEAYA Biosciences (IDYA): Can Its 15.3% Jump Turn into More Strength?
Zacks via Yahoo News· 6 days agoIDEAYA Biosciences (IDYA) was a big mover last session on higher-than-average trading volume. The...
Wildfire smoke linked to thousands of premature deaths every year in California alone
The Conversation via Yahoo News· 7 days agoBreathing wildfire smoke can cut years off people’s lives. As fires become more frequent in a...
Pfizer to move daily weight-loss pill to clinical trials
Evening Standard via Yahoo News· 4 days agoPfizer plans to move a version of its weight-loss pill danuglipron into clinical trials later this...
Psychedelic mushroom edibles promise health benefits. Be wary, experts say.
Washington Post via Yahoo News· 4 days agoThe chocolates and gummies come packaged in retro trippy colors, adorned with melting mushrooms and...
Trending tickers: Tesla, Nvidia, Pfizer and Superdry
Yahoo Finance UK· 3 days agoTesla (TSLA) Tesla shares were lower in pre-market trading after dropping over 8% during Thursday’s session as the company’s share of US electric vehicle...
Here's Why You Should Invest in Beam Therapeutics (BEAM) Now
Zacks via Yahoo News· 4 days agoBeam Therapeutics Inc. BEAM is evaluating its leading ex-vivo genome-editing candidate, BEAM-101, in...